Alejo Santa Cruz, M.D. Receives Caring for People Award

Posted on Jun 1, 2021 in Announcements | 0 comments

Alejo Santa Cruz, M.D. Receives Caring for People Award
Dr. Alejo Santa Cruz has been recognized for consistently showing exemplary skillful care to patients, specifically his guidance and assistance with the Covid Unit on 6SW at the Alta Bates Campus. Alejo has partnered with staff on best practices and continuously thanked our nursing team and employees for their dedication. We truly appreciate and thank Alejo and congratulate him on this much deserved award.

Patient Experience at ABSMC

Posted on Mar 2, 2021 in Announcements | 0 comments

Patient Experience at ABSMC

Gaunt and disheveled, Ms. R looked emotionally and physically exhausted.  She had been somehow managing to live in her car with severe lupus arthritis. Then she developed a high fever and could not get her wheelchair in and out of the vehicle so she drove herself to the ED. I saw her the next morning.  Sitting at the bedside, I said, “Ms. R, you must have been really suffering these last few days and frightened, too.”  Then taking her hands I said, “You can take a deep breath and relax now.  You are in the caring hands of the beautiful people at Alta Bates Summit.  We will care for you like family: we will clean you, comfort you and provide expert medical care – all with a whole lotta Love!  You can rest easy now; my friend, you are in good hands.”

“God bless you, doctor!” she said with tears rolling down her face.  My eyes were damp and my body almost pulsed with meaning as I left the room.  Trying to see the world from her perspective, I felt I had started to meet her needs.  Judging, by the way I felt, I must have done something good for me as well.

It is a little different for each of us, but we know it when great patient experience happens.  It is the goal of the ABSMC MD Communication Task Force to help us have more of these moments.

This is the first of the ABSMC newsletter posts from the Patient Experience – MD Communication Task Force. We are reaching out to the medical staff because patient experience is important for some many reasons:

  • A good experience promotes healing and adherence
  • Our patients stories are the best way to spread the word about the good work we do
  • Patient Experience data can affect the medical center’s bottom line in several ways
  • Connecting with patients deeply and witnessing their great experiences with the our processes and our staff are crucial for our own wellbeing

In the coming months we will share our data on patient experience and offer tips for you to improve your wellbeing, while also improving the patient’s wellbeing.  We look forward to sharing this with you and inspiring your engagement in the process.

Thanks and look forward to sharing more soon!

Leif Hass, Ursi Boynton and ABSMC Patient Experience MD Communication Task Force

Research and Pharmacy Teams Collaborate on Historic “Win” for ABSMC

Posted on Feb 1, 2021 in Announcements | 0 comments

EBAC Helps Prolong and Improve the Lives of Those Afflicted with HIV

Posted on Feb 1, 2021 in Announcements | 0 comments

While the world begins immunizing the public against COVID-19, our EBAC team led by Christopher Hall, M.D., is leading a research initiative in the East Bay that may provide even more HIV prevention options. Thank you to our EBAC staff members for their amazing work.

CDC Update to Gonococcal Infection Treatment

Posted on Feb 1, 2021 in Announcements | 0 comments

CDC Update to Gonococcal Infection Treatment

Neisseria gonorrhoeae is an important cause of sexually transmitted diseases and can lead to complications such as pelvic inflammatory disease, ectopic pregnancy, and infertility. While effective treatment can prevent complications and transmission, N. gonorrhoeae can rapidly develop resistance to antibiotics.

In December 2020, the CDC has updated its guidelines on gonococcal treatment. The CDC now recommends a single 500 mg intramuscular (IM) dose of ceftriaxone for treatment of uncomplicated gonococcal infection of the urogenital, anorectal, and/or pharyngeal region. For patients weighing 150 kg or more, 1 gram of ceftriaxone IM is recommended. In cases where chlamydial infection remains in the differential, doxycycline 100 mg orally twice daily for 7 days is recommended. Prior guidelines from 2010 recommended a single 250 mg IM dose of ceftriaxone and a single 1 gram dose of oral azithromycin.

This change in recommendation comes from increasing N. gonorrhoeae resistance to azithromycin. In the United States, N. gonorrhoeae resistance to azithromycin increased from 0.6% in 2013 to 4.6% in 2018. This, along with additional evidence concerning for reduced efficacy of azithromycin to treat chlamydial infections, especially rectal infections, has led to the decrease in strength of recommendation for azithromycin. In pregnant patients, oral azithromycin 1 gram as a single dose is still recommended to treat chlamydia. Meanwhile, N. gonorrhoeae remains susceptible to ceftriaxone. However, pharmacokinetic and pharmacodynamic studies demonstrate the need for higher ceftriaxone doses to avoid treatment failure, especially for pharyngeal gonorrhea treatment. Monitoring for emergence of ceftriaxone resistance will be essential for ensuring continued efficacy of the recommended regimens.


St. Cyr S, Barbee L, Workowski KA, et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1911–1916. DOI: icon

Why Sutter Community Connect

Posted on Jan 4, 2021 in Announcements | 0 comments